STN: BL 125251 Proper Name: von Willebrand Factor/Coagulation Factor VIII Complex (Human) Tradename: Wilate Manufacturer: Octapharma Pharmazeutika Produktionsges.m.b.H., License #1646
Indication:
WILATE is indicated in children and adults with von Willebrand disease for:
On-demand treatment and control of bleeding episodes
Perioperative management of bleeding
WILATE is indicated in adolescents and adults with hemophilia A for:
Routine prophylaxis to reduce the frequency of bleeding episodes
On-demand treatment and control of bleeding episodes
Product Information
Supporting Documents
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
